한신메디칼

비상장계속사업자

HANSHINMEDICAL CO.,LTD.

김정열

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

한신메디칼

Business Reg. No. 1308117456 · CEO 김정열

I.Investment Overview

Target한신메디칼 (1308117456)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명한신메디칼
영문명HANSHINMEDICAL CO.,LTD.
대표자김정열
사업자등록번호1308117456
법인등록번호1243110018625
설립일1987.01.01

V.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW123.82021143.52022134.42023122.52024121.72025
영업이익100M KRW3.720218.9202210.520237.320244.72025
순이익100M KRW3.420218.9202210202310.320244.12025
Item20252024202320222021
자산총계186.6억원181.3억원175.2억원174.9억원177.4억원
부채총계23.1억원21.8억원26.1억원35.7억원47.2억원
자본총계163.5억원159.4억원149.1억원139.1억원130.2억원
매출액121.7억원122.5억원134.4억원143.5억원123.8억원
영업이익4.7억원7.3억원10.5억원8.9억원3.7억원
순이익4.1억원10.3억원10억원8.9억원3.4억원

VI.Financial Ratios

FY2025 basis

3.84%

영업이익률

3.34%

순이익률

2.18%

ROA

2.49%

ROE

14.15%

부채비율

87.61%

자기자본비율

VII.R&D Activity

Fields 보건의료 > 의료기기

Keywords 예열 시스템

YearProjectsPapersPatents
2015013
2014103
2013100

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

한신메디칼 투심보고서 | Alpha Lenz